2C77.1ICD-11 MMS 2026-01
Adenocarcinoma of cervix uteri
Description
An adenocarcinoma arising from the cervical epithelium. It accounts for approximately 15% of invasive cervical carcinomas. Increased numbers of sexual partners and human papillomavirus (HPV) infection are risk factors. Grossly, advanced cervical adenocarcinoma may present as an exophytic mass, an ulcerated lesion, or diffuse cervical enlargement. Microscopically, the majority of cervical adenocarcinomas are of the endocervical (mucinous) type.
Coding note from above levels
Includes Malignant neoplasm of skin of female genital organs
For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.
Index terms
- Adenocarcinoma of cervix uteri
- Adenoid basal carcinoma of cervix uteri
- Adenoid cystic carcinoma of cervix uteri
Exclusions from above levels
2E05.Y– Malignant neoplasm metastasis in cervix2E05– Malignant neoplasm metastasis in female reproductive system- http://id.who.int/icd/entity/1965082709 – Malignant mesenchymal neoplasms
Show allHide
- http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
- http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues
Sibling codes
Foundation entity
Adenocarcinoma of cervix uteri – http://id.who.int/icd/entity/261293318
Allowed postcoordination axes
Part of: 2C77: Malignant neoplasms of cervix uteri › 02: Neoplasms